Tesamorelin 10mg: GHRH Research Peptide

Form: Lyophilized Powder
Purity: >99%

Product Description

Tesamorelin 10mg has been studied for its potential mechanism of action, posited to be similar to growth hormone-releasing hormones (GHRH) receptors located at the anterior pituitary gland, possibly leading to increased production and secretion of growth hormones. Growth hormones may act on several cells, including hepatocytes, stimulating the systemic synthesis of insulin-like growth factor-1 (IGF-1). In addition, growth hormone may also stimulate IGF-1 production locally, inside various tissues.

Tesamorelin appears to stimulate the release of growth hormone, and consequently IGF-1, by potentially interacting with the GHRH receptors in the anterior pituitary gland cells. When Tesamorelin interacts with the GHRH receptor, it is hypothesized that this interaction might alter the receptor’s structure, potentially initiating communication pathways within the cell. It is also theorized that Tesamorelin might enhance the production of cyclic adenosine monophosphate (cAMP) in certain cells, possibly through stimulation of adenylate cyclase, an enzyme that converts adenosine triphosphate (ATP) into cAMP.

Increased cAMP levels may lead to the activation of protein kinase A (PKA), an enzyme critical for transmitting signals within cells. Activated PKA may phosphorylate various target proteins, triggering a cascade of cellular responses. This stimulation of the GHRH receptor by Tesamorelin and the cAMP-PKA signaling pathway might promote the secretion and distribution of growth hormone (hGH) from somatotroph cells in the pituitary gland.

Research indicates this peptide may lead to an estimated 69% increase in overall growth hormone levels and a 55% increase in mean pulse area of growth hormone, while IGF-1 levels apparently surged by 122%.

Specific alterations at the N-terminus and C-terminus of the GHRH molecule in Tesamorelin enhance peptide stability and resistance to enzymatic deactivation. The C-terminus is modified with a trans-3-hexenoic acid group, and the N-terminus is acetylated (CH₃CO-), resulting in the chemical designation N-(trans-3-hexenoyl)-[Tyr1]hGRF(1–44)NH2 acetate.

Product Specifications

• Peptide Name: Tesamorelin 10mg
• Concentration: 10mg per vial
• Format: Lyophilized Professional Grade Powder
• Molecular Formula: C221H366N72O67S
• Molecular Weight: 5136 g/mol
• Other Names: (3E)-hex-3-enoylsomatoliberin
• Storage: Store at -20°C to maintain stability and bioactivity

Core Research Focus Areas

1. GHRH Receptor Activation: Studying pituitary stimulation and growth hormone release.
2. IGF-1 Modulation: Investigating systemic and local insulin-like growth factor-1 synthesis.
3. Lipolytic Effects: Potential impact on fat breakdown in abdominal and visceral adipose tissue.
4. Molecular Stability Studies: Assessing the effect of N- and C-terminal modifications on peptide longevity and enzyme resistance.
5. cAMP-PKA Signaling Pathway Research: Exploring intracellular signaling and protein phosphorylation cascades.

Why Source from Bionex Peptides?

• Premium Research Grade: Only the highest-quality peptides for laboratory studies.
• Reliable & Consistent: Manufactured for reproducible experimental outcomes.
• Fast & Secure Shipping: Temperature-controlled and discreet delivery across the United States.

Related Resources

• Explore more research peptides: Bionex Research Peptides
• Browse all products in our shop: Bionex Shop
• Wiki / Reference: Tesamorelin on Wikipedia